[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371882-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371882-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteomic-profiling-of-extracellular-vesicles-distinguishes-prostate-cancer-molecular-subtypes","Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes","","Prostate cancer is the most common non-cutaneous cancer in U.S. men, with many tumors driven by androgen receptor (AR) signaling. A growing subset loses AR and gains neuroendocrine (NE) features (AR−/NE+) or lacks both (AR−/NE−), producing particularly aggressive, lethal disease. Using shotgun proteomics with mass spectrometry, researchers profile EVs from prostate cancer models spanning these clinical subtypes, identify 3952 EV proteins, and derive AR or NE gene signatures relevant to prognosis. EVs from AR+ cells reflect AR and mTOR-regulated proteins, whereas AR−/NE+ EVs contain NE markers (SYP, CHGA) and AR−/NE− models enrich basal markers and EMT regulators. Cell line data are integrated with EV proteomics from 27 patients, yielding 2733 overlapping proteins including subtype-enriched and prostate cancer–relevant surface markers, supporting liquid biopsy optimization for rare molecular states.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteomic-profiling-of-extracellular-vesicles-distinguishes-prostate-cancer-molecular-subtypes/371882/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteomic-profiling-of-extracellular-vesicles-distinguishes-prostate-cancer-molecular-subtypes/371882.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What molecular subtypes of prostate cancer are studied in this work?","Question",{"text":63,"@type":64},"The study focuses on AR-driven tumors and subtypes that lose AR signaling. It specifically considers AR−/NE+ (neuroendocrine) and AR−/NE− (double negative) models, which are described as particularly aggressive.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were extracellular vesicles (EVs) analyzed to distinguish these subtypes?",{"text":68,"@type":64},"Researchers used shotgun proteomics with mass spectrometry to interrogate the global proteome of EVs isolated from prostate cancer cell lines representing diverse clinical subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"What type of biomarkers do the authors propose EV proteomics could provide?",{"text":72,"@type":64},"The work identifies EV protein signatures that reflect AR or NE identity, and it integrates cell line findings with patient EV proteomics to highlight subtype-enriched markers. This is positioned as useful for clinical decision-making using non-invasive liquid biopsy samples.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371882,1790217424,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Journal of Extracellular Vesicles  \nRESEARCH ARTICLE   \nProteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes  \nMegan L. Ludwig1   Ali T. Arafa1  Saasha Vinoo1  Jason C. Jones1   Abderrahman Day2  Hannah E. Bergom2 Zoi Sychev1, 3  Alec Horrmann1  Nicholas M. Levinson1  Scott M. Dehm3, 4, 5  Emmanuel S. Antonarakis2, 5  Justin Hwang2, 5  Justin M. Drake1, 4, 5  \n1 Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA  2 Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA  3 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA  4 Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA  5Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA  \nCorrespondence: Justin M. Drake ([jdrake@umn.edu](jdrake@umn.edu))  \nReceived: 17 February 2025  Revised: 18 August 2025  Accepted: 12 September 2025  \nFunding: M.L.L. and J.C.J. were supported by the Targets of Cancer Training Program Fellowship (T32 CA009138). [A.T.A. is](A.T.A. is) supported by a Postdoctoral Fellowship, PF-23-1153194-01-CDP, Grant \\#: [[https://doi.org/10.53354/ACS.PF-23-1153194-01-CDP.pc.gr.175399](https://doi.org/10.53354/ACS.PF-23-1153194-01-CDP.pc.gr.175399)]. S.M.D. is partially supported by NCI grants R01CA174777 and R01CA270539 . E.S.A. is partially supported by NCI grant P30 CA077598 and DOD grant W81XWH-22-2-0025 . J.M.D. is supported by the Masonic Cancer Center at the University of Minnesota and by the National Institutes of Health NCI R01CA269801 . This work was also partially supported by a Masonic Cancer Center Cancer Research Translational Initiative (CRTI) pilot grant.  \nABSTRACT  \nProstate cancer is the most common non-cutaneous cancer among men in the United States. Most prostate cancers are driven by androgen receptor (AR) signalling, but there are an increasing number of cases that lose AR and gain neuroendocrine (NE) features (AR−/NE+) or lack both (AR−/NE−) . These latter subtypes are particularly aggressive and lethal. Extracellular vesicles (EVs) have shown great potential as biomarkers for non-invasive liquid biopsy assays, as EVs contain biomolecules from their cells of origin. Here, we used a shotgun proteomics approach with mass spectrometry to interrogate the global proteome of EVs isolated from prostate cancer cell lines reflecting diverse clinical subtypes, including AR−/NE+ andAR−/NE − models. We identified 3952 EV proteins, which clustered largely by tumour subtype and provided enough proteomic coverage to derive classic gene signatures of AR or NE identity that are of high relevance for prostate cancer prognostication. EVs isolated from AR+ cells displayed high levels of proteins regulated by AR and mTOR signalling. EVs isolated from AR−/NE+ cells contained known NE markers such as SYP and CHGA, whereas EVs from AR−/NE − models were enriched in basal cell markers and proteins that regulate epithelialto-mesenchymal transition (EMT). We integrated our cell line data with recently published EV proteomics data from 27 advanced prostate cancer patients and found 2733 overlapping proteins, including cell surface markers relevant to prostate cancer, AR activity indicators, and proteins enriched in specific subtypes (AR+, AR−/NE−, AR−/NE+) . This approach may be useful for rare cancer subtypes, such as prostate cancers that lose AR-related features and gain NE features, to optimise the use of these liquid biopsy samples for clinical decision making.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s) . Journal of Extracellular Vesicles published by Wiley Periodicals LLC on behalf of International Society for Extracellular Vesicles.  \nJourn","cbCaiiqvjMw6Z18c","https://ap.wps.com/l/cbCaiiqvjMw6Z18c","pdf",3337244,14,"English","# Introduction\n## Androgen receptor signaling and prostate cancer progression\n## Molecular subtypes: AR−/NE+ and AR−/NE−\n## Extracellular vesicles as liquid biopsy biomarkers","[{\"question\":\"What molecular subtypes of prostate cancer are studied in this work?\",\"answer\":\"The study focuses on AR-driven tumors and subtypes that lose AR signaling. It specifically considers AR−/NE+ (neuroendocrine) and AR−/NE− (double negative) models, which are described as particularly aggressive.\"},{\"question\":\"How were extracellular vesicles (EVs) analyzed to distinguish these subtypes?\",\"answer\":\"Researchers used shotgun proteomics with mass spectrometry to interrogate the global proteome of EVs isolated from prostate cancer cell lines representing diverse clinical subtypes.\"},{\"question\":\"What type of biomarkers do the authors propose EV proteomics could provide?\",\"answer\":\"The work identifies EV protein signatures that reflect AR or NE identity, and it integrates cell line findings with patient EV proteomics to highlight subtype-enriched markers. This is positioned as useful for clinical decision-making using non-invasive liquid biopsy samples.\"}]","Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes | PDF",1790193097,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17bbfd2bfe611ce5c389ae994fc273e3.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48abff534966374ef55a1910ed7f2df7.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04efd669d6c0ded69616365406b6f2b6.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9affe8a782e747430b8b3bdf45208af9.webp",980,1287]